Previous 10 | Next 10 |
2023-05-24 06:33:55 ET U.K.-based Advanz Pharma signed an agreement to get exclusive rights from Alvotech ( NASDAQ: ALVO ) to commercialize five proposed biosimilars in Europe. Alvotech said it will be responsible for development and commercial supply while Advanz will be...
2023-05-22 11:43:35 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips AVROBIO (NASDAQ: AVRO ) stock is seeing massive gains on Monday as the company sells one of its gene therapies to Novartis (NYSE: NVS ). This deal has No...
2023-05-21 12:00:17 ET Developers have increasingly relied on an FDA shortcut to win accelerated drug approvals while their confirmatory trials got delayed at the expense of billions to the government-backed healthcare system, a recent analysis from Bloomberg News indicates. The...
2023-05-18 18:00:00 ET Summary I consider companies that combine a relatively high Dividend Yield and Dividend Growth Rate to be particularly attractive for dividend income investors. The reason being that these companies can help you to significantly increase your extra income in...
2023-05-17 05:06:24 ET Roche ( OTCQX:RHHBY ) ( OTCQX:RHHBF ) said its oral drug fenebrutinib met the main and secondary goals of a phase 2 trial by reducing brain lesions in adults with relapsing forms of multiple sclerosis (RMS). The 12-week mid-stage study, dubbed FENopta...
2023-05-16 16:46:23 ET Summary We continue our analytics coverage of AstraZeneca PLC with a "hold" rating for the next 12 months. AstraZeneca's revenue for the first three months of 2023 was $10.88 billion, down 2.9% from the previous quarter and 4.5% from the first quarter of 202...
2023-05-15 08:57:02 ET Swiss drugmaker Novartis ( NYSE: NVS ) named a 10-member board on Monday for its Sandoz generics drug business ahead of its planned spinoff in H2 2023. The team led by Sandoz Chairman-designate Gilbert Ghostine is expected to begin preparatory work in June...
2023-05-14 07:16:59 ET Summary BCYC's distinction is that it is founded by a Nobel laureate. However, unless it can differentiate its product's efficacy from that of mAbs, that may be its only distinction. So far, it has not been strikingly successful. I covered Bicy...
2023-05-14 06:57:39 ET Summary WisdomTree International Quality Dividend Growth Fund holds global dividend stocks with quality and growth characteristics. It is well-diversified across countries and sectors, but it is quite concentrated in the top holdings. Historical performa...
2023-05-14 03:56:00 ET Summary Industry-leading pharmaceutical firms are adopting artificial intelligence to drive value for the future of their enterprise. Several companies in the VanEck Pharmaceutical ETF are currently integrating AI into their operations. The global pharma...
News, Short Squeeze, Breakout and More Instantly...
2024-07-19 04:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-18 16:45:16 ET Image source: The Motley Fool. Novartis Ag (NYSE: NVS) Q2 2024 Earnings Call Jul 18, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Novartis Ag (NVS) Q2 2024 Earnings Call Transcript
2024-07-18 14:15:34 ET By most standards shares of drugmaker Novartis (NYSE: NVS) should be higher following this morning's release of its second-quarter results. The drugmaker's top and bottom lines were both better than expected, and up from year-earlier comparisons. And profit gu...